APGE
Apogee Therapeutics (APGE)
$78
About Apogee Therapeutics (APGE)
Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded in 2022 and is headquartered in Waltham, MA.
Details
Daily high
$77.50
Daily low
$74.52
Price at open
--
52 Week High
$78.15
52 Week Low
$26.20
Market cap
4.5B
Dividend yield
0.00%
Volume
350
Avg. volume
849,673
P/E ratio
-17.32
Apogee Therapeutics News
Details
Daily high
$77.50
Daily low
$74.52
Price at open
--
52 Week High
$78.15
52 Week Low
$26.20
Market cap
4.5B
Dividend yield
0.00%
Volume
350
Avg. volume
849,673
P/E ratio
-17.32